BLAC Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bellevue Life Sciences Acquisition Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.13 |
| 52 Week High | US$13.40 |
| 52 Week Low | US$10.43 |
| Beta | 0 |
| 11 Month Change | 1.64% |
| 3 Month Change | 2.49% |
| 1 Year Change | 6.71% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 10.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| BLAC | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -6.4% | 3.0% | 2.2% |
| 1Y | 6.7% | 57.6% | 31.6% |
Return vs Industry: BLAC underperformed the US Capital Markets industry which returned 57.5% over the past year.
Return vs Market: BLAC underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| BLAC volatility | |
|---|---|
| BLAC Average Weekly Movement | 5.1% |
| Capital Markets Industry Average Movement | 3.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BLAC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: BLAC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Peter Hwang | www.bellevuespac.com |
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.
Bellevue Life Sciences Acquisition Corp. Fundamentals Summary
| BLAC fundamental statistics | |
|---|---|
| Market cap | US$44.98m |
| Earnings (TTM) | -US$474.86k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-94.7x
P/E RatioIs BLAC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLAC income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$474.86k |
| Earnings | -US$474.86k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -30.9% |
How did BLAC perform over the long term?
See historical performance and comparison